Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2003
11/13/2003CA2484155A1 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003CA2483929A1 A method for inhibiting platelet aggregation
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483478A1 Factor vii or viia polypeptide variants
11/13/2003CA2483456A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/13/2003CA2483001A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361276A1 Pro-urokinase mutants
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361220A1 Cyclic compounds having thrombopoietin receptor agonism
11/12/2003EP1361213A1 Process for preparation of cyanophenylbenzoic acid derivatives
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360319A2 Diagnosis of diseases associated with metabolism
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359947A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
11/12/2003EP1359936A2 Combined use of factor vii polypeptides and factor viii polypeptides
11/12/2003EP1359935A1 Combined use of factor vii polypeptides and factor ix polypeptides
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1255557B1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation containing desmopressin
11/12/2003EP1146895B1 Thrombopoietin compositions for increasing circulating platelets
11/12/2003EP1133308B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/12/2003EP0886648B1 Compounds and peptides that bind to the erythropoietin receptor
11/12/2003EP0768892B1 Thrombolytic composition
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1455678A Methods of therapy with thrombin derived peptides
11/12/2003CN1455676A Chinese-herb composition and method for preparing same
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
11/12/2003CN1454667A Convenient fibrin blocking agent
11/12/2003CN1454629A Medicine for clinical hemostasis and preparing method thereof
11/12/2003CN1454625A Dampness-removing embolism-dissolving medicine
11/12/2003CN1454624A Dampness-removing embolism-dissolving medicinal liquor
11/12/2003CN1454596A Compound medicine of ginkgo leaf extract and dipyridamole and preparing method thereof
11/12/2003CN1454590A Ethylenediamine diaceturate lyophilized powder injection and preparing method thereof
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646120 Polysaccharides with side chains of methylcarboxylate, carboxymethylbenzylamide, sulfate and sulfonate groups; use as anti-thrombotic, substitute for plasma and modulator of cell proliferation
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091442A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091284A1 Anticoagulants
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091239A1 Estrogen receptor modulators
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003090793A1 Removal of adenine during a process of pathogen reducing blood and blood components
11/06/2003WO2003090767A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof
11/06/2003WO2003090759A1 Difructose anhydride-containing composition and use thereof
11/06/2003WO2003090750A1 Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003090740A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
11/06/2003WO2003090726A2 Chewable soft capsule
11/06/2003WO2003090708A1 External preparation for skin
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003090665A2 Regulation of erythrocyte apoptosis
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/06/2003WO2003076458A3 Selective dipeptide inhibitors of kallikrein
11/06/2003WO2003057166A3 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003WO2003049694A3 Methods of therapy for non-hodgkin's lymphoma
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003018640A3 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002064567A3 Substituted carboxamides as inhibitors of factor xa
11/06/2003WO2002063025A3 Muscle-directed gene therapy with aav-1 and aav-6 vectors
11/06/2003WO2002040039A3 In vivo use of water absorbent polymers
11/06/2003WO2002032435A3 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
1 ... 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ... 671